{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:21:39Z","timestamp":1777353699199,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA190617"],"award-info":[{"award-number":["CA190617"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ejmech.2018.11.056","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:52:08Z","timestamp":1542934328000},"page":"320-332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Development of posaconazole-based analogues as hedgehog signaling pathway inhibitors"],"prefix":"10.1016","volume":"163","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1319-5025","authenticated-orcid":false,"given":"Kelly A.","family":"Teske","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0696-4962","authenticated-orcid":false,"given":"Radha Charan","family":"Dash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shana R.","family":"Morel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianne Q.","family":"Chau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Wechsler-Reya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9482-1712","authenticated-orcid":false,"given":"M. Kyle","family":"Hadden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.11.056_bib1","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1101\/gad.938601","article-title":"Hedgehog signaling in animal development: paradigms and principles","volume":"15","author":"Ingham","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2018.11.056_bib2","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nrm3598","article-title":"The mechanisms of hedgehog signalling and its roles in development and disease","volume":"14","author":"Briscoe","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2018.11.056_bib3","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3389","article-title":"Unraveling the therapeutic potential of the hedgehog pathway in cance","volume":"19","author":"Amakye","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2018.11.056_bib4","first-page":"129","article-title":"Advanced basal cell carcinoma, the hedgehog pathway, and treatment options \u2013 role of smoothened inhibitors","volume":"9","author":"Fecher","year":"2015","journal-title":"Biologics"},{"key":"10.1016\/j.ejmech.2018.11.056_bib5","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/neuonc\/nou109","article-title":"Targeted treatment for sonic hedgehog-dependent medulloblastoma","volume":"16","author":"Kieran","year":"2014","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejmech.2018.11.056_bib6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.chembiol.2017.02.010","article-title":"Hedgehog signaling: from basic biology to cancer therapy","volume":"24","author":"Wu","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2018.11.056_bib7","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJMoa0902903","article-title":"Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449","volume":"361","author":"Rudin","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2018.11.056_bib8","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.1179386","article-title":"Smoothened mutation confers resistance to a hedgehog pathway inhibitor in medulloblastoma","volume":"326","author":"Yauch","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2018.11.056_bib9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ccell.2015.02.002","article-title":"Smoothened variants explain the majority of drug resistance in basal cell carcinoma","volume":"27","author":"Atwood","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2018.11.056_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ccell.2015.02.001","article-title":"Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma","volume":"27","author":"Sharpe","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2018.11.056_bib11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1158\/0008-5472.CAN-10-2876","article-title":"Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance","volume":"71","author":"Dijkgraaf","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2018.11.056_bib12","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/cmdc.201700792","article-title":"Structure-activity relationship studies of vitamin D3 analogues containing an ether or thioether linker as Hedgehog pathway inhibitors","volume":"13","author":"Wen","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2018.11.056_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-018-0220-7","article-title":"A\u00a0highlight on sonic hedgehog pathway","volume":"16","author":"Carballo","year":"2018","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejmech.2018.11.056_bib14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.drudis.2018.01.012","article-title":"Overcoming the resistance mechanisms of Smoothened inhibitors","volume":"23","author":"Dong","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2018.11.056_bib15","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1016\/j.bmcl.2018.08.033","article-title":"Current trends in Hedgehog signaling pathway inhibition by small molecules","volume":"28","author":"Ghirga","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.11.056_bib16","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/med.21482","article-title":"Strategies to target the Hedgehog signaling pathway for cancer therapy","volume":"38","author":"Xin","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2018.11.056_bib17","first-page":"388","article-title":"Itraconazole, a commonly used anti-fungal that inhibits Hedgehog pathway activity and cancer growth Cancer","volume":"17","author":"Kim","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2018.11.056_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ccr.2012.11.017","article-title":"Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists","volume":"23","author":"Kim","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2018.11.056_bib19","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1021\/acs.jmedchem.5b01718","article-title":"Repurposing the clinically efficacious antifungal agent itraconazole as an anticancer chemotherapeutic","volume":"59","author":"Pace","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.056_bib20","unstructured":"Pace, J. R.; Teske, K. A.; Chou, L. Q.; Wechsler-Reya, R. J.; Hadden, M. K. Structure-activity relationships for itraconazole-based triazolone analogues as hedgehog pathway inhibitors. J. Med. Chem. (Under Revision)."},{"key":"10.1016\/j.ejmech.2018.11.056_bib21","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1158\/1535-7163.MCT-15-0729-T","article-title":"Posaconazole, a second-generation triazole antifungal drug, inhibits the hedgehog signaling and progression of basal cell carcinoma","volume":"15","author":"Chen","year":"2016","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ejmech.2018.11.056_bib22","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1096\/fj.14-267849","article-title":"MRT-92 inhibits hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the smoothened receptor","volume":"29","author":"Hoch","year":"2015","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejmech.2018.11.056_bib23","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1016\/0040-4039(96)01203-8","article-title":"Concise asymmetric routes to 2,2,4-trisubstituted tetrahydrofurans via chiral titanium imide enolates: key intermediates towards synthesis of highly active azole antifungals SCH 51048 and SCH 56592","volume":"37","author":"Saksena","year":"1996","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2018.11.056_bib24","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1600-0625.2006.00465.x","article-title":"Long-term establishment, characterization and manipulation of cell lines from mouse basal cell carcinoma tumors","volume":"15","author":"So","year":"2006","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ejmech.2018.11.056_bib25","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1038\/onc.2014.304","article-title":"Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma","volume":"34","author":"Brun","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2018.11.056_bib26","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature12167","article-title":"Structure of the human smoothened receptor bound to an antitumour agent","volume":"497","author":"Wang","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.11.056_bib27","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2018.04.029","article-title":"Structural basis of smoothened activation in hedgehog signaling","volume":"174","author":"Huang","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2018.11.056_bib28","article-title":"Crystal structure of a multi-domain human smoothened receptor in complex with a super stabilizing ligand","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2018.11.056_bib29","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature18934","article-title":"Structural basis of Smoothened regulation by its extracellular domains","volume":"535","author":"Byrne","year":"2016","journal-title":"Nature"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418310158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418310158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:49:14Z","timestamp":1759326554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418310158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":29,"alternative-id":["S0223523418310158"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.11.056","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of posaconazole-based analogues as hedgehog signaling pathway inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.11.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}